Open Access Open Badges Short Report

Educational sessions in pharmacovigilance: What do the doctors think?

Antonio Vallano1*, Consuelo Pedrós1, Antonia Agustí2, Gloria Cereza2, Immaculada Danés2, Cristina Aguilera2 and Josep Maria Arnau1

Author Affiliations

1 Clinical Pharmacology Service, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital-ICS, Department of Pathology and Experimental Therapeutics, University of Barcelona, Feixa Llarga s/n, 08035 L'Hospitalet de Llobregat, Barcelona, Spain

2 Fundació Institut Català de Farmacología, Clinical Pharmacology Service, Hospital Universitari Vall d'Hebron, Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Pg Vall d'Hebron, n° 119-129, 08035 Barcelona, Spain

For all author emails, please log on.

BMC Research Notes 2010, 3:311  doi:10.1186/1756-0500-3-311

Published: 17 November 2010



The aim of this study was to determine physicians' opinion regarding pharmacovigilance feedback sessions. A survey was conducted in a teaching hospital, and the physicians who attended the sessions were invited to participate by filling out a structured questionnaire. All sessions included a review of adverse drug reactions identified at the hospital and information on pharmacovigilance issues (news on warnings released by regulatory agencies or drug toxicity problems identified by recently published studies in medical journals). The survey questions were related to the interest, satisfaction, and belief in the utility of the sessions. A Likert scale (0-10 points) was used to assess physicians' opinions.


A total of 159 physicians attended the sessions and 115 (72.3%) participated in the survey. The mean (SD) age was 38.9 (12.1) years, and 72 (62.6%) were men. The mean (SD) scores of interest, satisfaction with the information provided, and belief in the utility of these sessions were 7.52 (1.61), 7.58 (1.46), and 8.05 (1.38) respectively. Significant differences were observed among physicians according to medical category and speciality in terms of interest, satisfaction, and belief in the utility of those sessions.


Educational activities for physicians, such as feedback sessions, can be integrated into the pharmacovigilance activities. Doctors who attend the sessions are interested in and satisfied with the information provided and consider the sessions to be useful. Additional studies on the development and effectiveness of educational activities in pharmacovigilance are necessary.